Medifast, Inc. (MED) Q2 FY26 Earnings Call

Coach productivity improved, but shrinking coach count and GLP-1 pressure leave profitability dependent on Catalyst and new products.

Q2 FY26 results, source: company transcript and SEC filings
QuarterQ2 FY26
Call date2026-08-03
Length35 minutes
EPS$-0.28
EPS consensus$-0.67
Revenue$76.4M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

All MED earnings ยท Back to MED overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.